Novel inhaled antifungal for pseudomembranous Aspergillus tracheobronchitis complicating connective tissue disease

Thorax. 2023 Jan;78(1):110-111. doi: 10.1136/thorax-2021-218375. Epub 2022 Sep 29.

Shivani Singh¹, Luke S P Moore^{1

2

3}, Nabeela Mughal^{1

3}, Matthew Ho^{1

4}, Darius Armstrong-James^{1

5}, Suveer Singh^{6

7}

¹ Imperial College London, London, UK.
² NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Imperial College London, London, UK.
³ Clinical Infection Department, Chelsea and Westminster Healthcare NHS Trust, London, UK.
⁴ Department of Rheumatology, Chelsea and Westminster Healthcare NHS Trust, London, UK.
⁵ MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, UK.
⁶ Imperial College London, London, UK suveer.singh@imperial.ac.uk.
⁷ Respiratory and Intensive Care Medicine, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.

No abstract available

Keywords: Airway Epithelium; Aspergillus Lung Disease; Bronchoscopy.

MeSH terms